Abstract:Objectives: Mixed-phenotype acute leukemia (MPAL) is rare in the clinic, accounting for approximately 2%-5% of acute leukemia cases. Methods: In this study the cohort included 126 patients, of which 125 cases were from re-examined published data and current patients from Shenzhen Longhua District Central Hospital, carrying an ETV6-ABL1 rearrangement from April 15, 2020 to December 19, 2020. The ETS variant transcription factor 6-Abelson proto-oncogene 1 (ETV6-ABL1) fusion gene is mainly seen in malignant hematological diseases such as acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), myeloproliferative neoplasms (MPNs). Positivity of both MPAL and ETV6-ABL1 suggest a poor prognosis. This is the first report of B lymphocytic/myeloid mixed-phenotype acute leukemia with ETV6-ABL1 fusion gene positivity. Complete remission was achieved with chemotherapy for lymphoid and myeloid leukemia and targeted therapy with tyrosine kinase inhibitors (TKIs). Results: The level of ETV6-ABL1/ABL decreased from 23.056% to 11.165%. After consolidation chemotherapy, the patient underwent allogeneic hematopoietic stem cell transplantation but died due to intestinal rejection. There are 126 cases of ETV6-ABL1 fusion gene transcript expression in numerous hematologic malignancies reported to date, including 48 cases of ALL, 12 of AML, and 65 of MPN. Eosinophilia is a common characteristic, especially in MPN patients. Conclusion: Survival analysis suggests that the survival time of ALL and MPN patients receiving TKI treatment is better than that of patients not receiving this treatment. Dasatinib or nilotinib, especially the former, is more effective than imatinib for MPN. doi: https://doi.org/10.12669/pjms.40.6.8497 How to cite this: Wang L, He D, Lu L, Wang H, Wang S. Mixed-phenotype (B-lymphocytic/myeloid) acute leukemia with ETV6-ABL1 expression. Pak J Med Sci. 2024;40(6):1294-1299. doi: https://doi.org/10.12669/pjms.40.6.8497 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

A case of adult ETV6-ASCL6 fusion gene positive chronic myeloproliferative tumor and literature review

ETV6-ACSL6 Fusion Gene in Myeloid Neoplasms: Clinical Spectrum, Current Practice, and Outcomes

Myeloid Neoplasm with the Abnormality of PDGFRB Gene Secondary Interstitial Pneumonia: A Case Report

Secondary Mixed Phenotype Acute Leukemia Following Chemotherapy for Diffuse Large B-cell Lymphoma: a Case Report and Review of the Literature.

Myeloproliferative Neoplasm with ETV6-ABL Rearrangement Conferred a Granulocyte Proliferation Bias

Pulmonary Leucostasis And Trisomy 12 In A Young Patient With Chronic Lymphocytic Leukemia: A Case Report And Review Of Literature

Exploration of ETV6::ABL1-positive AML with concurrent NPM1 and FLT3-ITD mutations

Mixed-phenotype (B-lymphocytic/myeloid) acute leukemia with ETV6-ABL1 expression

Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia

[Distribution of ETV6-ABL Fusion Gene in Hematopoietic Cell Populations of Myeloproliferative Neoplasm].

Characterization of leukemias with ETV6-ABL1 fusion

Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review

Pediatric Chronic Myeloid Leukemia with a BCR- FIBCD1-ABL1 Fusion Transcript: a Case Report and Literature Review

Acute myeloid leukemia with NPM-MLF1 fusion gene: report of one case and review of literature

ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate

Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion

B﹣cell acute lymphoblastic leukemia with E2A﹣HLF fusion gene: report of two cases and review of literature

Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review

Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review

AEL transformed from post-ET myelofibrosis with a sinusoidal pattern, JAK2 mutation, and biallelic TP53 inactivation

ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression